GLP-1 Revolution
by Amaltash Advisors LLC
$417.80
+8.86% past month
Nov 16, 2026
$417.80+0.33%
Comparable surgical and medical instruments companies fell 0.94% on average, with all 6 of 6 declining . West Pharmaceutical Services closed up 0.33%, so its move was not shared by the cohort .
Nov 13, 2026
$416.42+1.24%
Nov 12, 2026
$411.30-0.38%
Comparable surgical and medical instruments companies moved -0.84% on average, with 2 of 6 falling and 4 rising . The shares fell 0.38%, a smaller decline than the cohort average, and traded on volume at 0.5x the trailing 20-session average .
Nov 11, 2026
$412.86+0.08%
Comparable surgical and medical instruments companies rose 0.95% on average, with 5 of 6 rising . WST was close to flat, up 0.08%, so it did not share in the cohort's gain . Volume was 0.4x its trailing average .
Nov 10, 2026
$412.55-0.13%
Nov 9, 2026
$413.09+3.32%
Comparable surgical and medical instruments companies rose 2.17% on average, with all 6 of the 6 tracked rising . West's 3.32% gain came alongside that sector-wide advance .
Nov 6, 2026
$399.81+1.87%
West's shares rose 1.87% while comparable surgical and medical instruments companies moved -0.51% on average, with 4 of 6 falling and 2 rising . The gain was therefore not shared by the cohort, which was slightly lower on the session .
Closing prices for WST. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.
As of Nov 16, 2026, West Pharmaceutical Services, Inc. closed at its 52-week high. Its largest decline in the period shown was -59.6% (Dec 30, 2021 to Apr 8, 2025).
As of Nov 16, 2026, West Pharmaceutical Services, Inc. closed at its 52-week closing high.
West Pharmaceutical Services, Inc. fell 59.6% from Dec 30, 2021 to Apr 8, 2025, close to close, the largest decline in daily data since Nov 18, 2021. It had not closed back above that high as of Nov 16, 2026.
Learn how max drawdown is measured, and how past market drawdowns played out.
Daily closing prices from Nov 18, 2021 to Nov 16, 2026, adjusted for splits but not dividends. Past price movements do not predict future results.
How much would it be worth today? $1,000 invested in West Pharmaceutical Services, Inc. (WST) 10 years ago, at the Nov 30, 2016 close, would be worth about $5,148 today, based on the Nov 16, 2026 close — a gain of $4,148 (+414.8%), dividends not included. Along the way it fell as much as 59.9% from a high, between Sep 2021 and Apr 8, 2025. Before Nov 2021 this uses monthly highs and lows.
Return calculator
Worth today, at the Nov 16, 2026 close
$31,784
+$18,884 · +146.4%The cash line is the same deposits earning nothing. A savings account would usually have paid some interest.
Past performance of WST's closing prices (split-adjusted; dividends not included). It ignores fees, taxes and trading costs. The results change as prices update and with the amounts you enter. Past results do not predict future results, and a single stock can fall hard. We show this for every asset in our directory; it is not a recommendation to buy or sell WST.
Try the full investment calculatorThe coffee test
A $5 coffee every workday comes to about $100 a month. Over 5 years that's 1,200 coffees, or $6,000.
The same $100 a month put into WST since November 2021 would be worth $8,221 today.
That's 1,644 coffees. Make it a large.
Past performance, month-end prices. Not a forecast.
| Invested | Start date | WST price then | $1,000 → | $10,000 → | Change |
|---|---|---|---|---|---|
| 1 year | Nov 28, 2025 | $277.25 | $1,507 | $15,069 | +50.7% |
| 3 years | Nov 30, 2023 | $350.76 | $1,191 | $11,911 | +19.1% |
| 5 years | Nov 30, 2021 | $442.66 | $944 | $9,438 | -5.6% |
| 10 years | Nov 30, 2016 | $81.15 | $5,148 | $51,485 | +414.8% |
$10,000 invested in West Pharmaceutical Services, Inc. (WST) at the Nov 30, 2016 close would have been worth about $51,485 at the Nov 16, 2026 close — a gain of $41,485 (+414.8%), dividends not included.
WST closed at $81.15 on Nov 30, 2016 (split-adjusted). It closed at $417.80 on Nov 16, 2026.
Putting $100 into WST at each month-end close from Nov 30, 2016 — 120 purchases, $12,000 in total — would have been worth about $27,151 at the Nov 16, 2026 close: a gain of $15,151 (+126.3%), dividends not included.
WST closed at $417.80 on Nov 16, 2026. A year earlier it closed at $261.36 on Nov 14, 2025, so it is up 59.9% over that year. Five years earlier it closed at $429.88 on Oct 29, 2021 (down 2.8% since then). Its highest close in the year to Nov 16, 2026 was $417.80 on Nov 16, 2026, and its lowest was $230.95 on Feb 3, 2026. These are split-adjusted closing prices; dividends are not included.
WST last closed at $417.80 on Nov 16, 2026. This page is updated once a day, so it does not show live prices.
Over one year, from $261.36 on Nov 14, 2025 to $417.80 on Nov 16, 2026, it was up 59.9%. Over five years, from $429.88 on Oct 29, 2021 to $417.80 on Nov 16, 2026, it was down 2.8%. These are split-adjusted closing prices; dividends are not included.
As of Nov 16, 2026, West Pharmaceutical Services, Inc. had a market value (market cap) of about $29 billion and a price-to-earnings (P/E) ratio of 48.2.
West makes stoppers, seals and other parts that hold medicines given as shots. It also makes devices for giving shots and builds medical devices for other companies.
We do not tell anyone whether to buy or sell WST, and past results do not predict future results. Its largest fall from a high since Nov 18, 2021 was 59.6%, from $471.34 on Dec 30, 2021 to $190.39 on Apr 8, 2025. A single stock can lose much of its value, so think about how much you could afford to lose. Our investment calculator shows how past amounts would have changed.
Past performance of WST's closing prices. Not a forecast. This is general information, not a recommendation to buy or sell WST.
Try the full investment calculatorThese strategies on Amaltash hold WST today. We show them so you can see where it is used. This is not a recommendation to invest in any of them.
by Amaltash Advisors LLC